How do you pay?

How to pay the least

Lowest posted price

as little as $60 a prescription

Alvesco from Covis Pharma (Azurity Pharmaceuticals), without insurance.

  1. Sign up for Alvesco eVoucher Program / Alvesco Cash Program. Or call 1-844-289-3981.Sign up on alvesco.com 

No generic is sold yet.

Compare every option

Question
Brand nameAlvesco
Authorized genericciclesonide
Regular genericciclesonide
What you’d pay
As little as$60a prescription from the maker
Not soldThere isn’t one
Not soldNone sold yet
Same as Alvesco?
The original
–
–

Brand nameThe maker’s card

Alvesco eVoucher Program / Alvesco Cash Program

Savings card from Covis Pharma (Azurity Pharmaceuticals)

No insurance · as little as $60 a prescription
Insurance · as little as $60 a prescription

Sign up on alvesco.com 

Or call 1-844-289-3981.

In the maker’s words

“At participating pharmacies, eligible patients with commercial insurance may pay as little as $60 per prescription through the Alvesco eVoucher program.”

“Inhalers may be available for as little as $60 per prescription.”

From the maker’s offer on alvesco.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s price above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Alvesco itself, from the same company, sold without the brand name, and usually for less. For now Alvesco is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

ALVESCO is an inhaled corticosteroid indicated for maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 12 years of age and older.

Limitations of Use:

ALVESCO is not indicated for the relief of acute bronchospasm or in pediatric patients less than 12 years of age.

Source: the FDA label for Alvesco (Covis Pharma US, Inc), February 28, 2025. Full label on DailyMed 

Good to know